A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Colorectal Cancer|Breast Cancer|Lung Cancer|Pancreatic Cancer|Colon Cancer
Interventions: BIOLOGICAL: AVX701|BIOLOGICAL: AVX701|BIOLOGICAL: AVX701|BIOLOGICAL: AVX701|BIOLOGICAL: AVX701
Sponsor: AlphaVax, Inc.
Collaborators: Duke University